QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
Public ClinicalTrials.gov record NCT07661823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A Quantum AI Public Health Agency That Provides Free Public Health Services to Registered and Sponsored Visitors/Occupants for RDT&E Under 28 U.S. Code 1498 (Classified as a PPA Under 10 U.S. Code 129a)
Study identification
- NCT ID
- NCT07661823
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Veterans Recovery Network Inc.
- Other
- Enrollment
- 1,000,000 participants
Conditions and interventions
Conditions
- Asperger's Disorder
- Asperger Disorder
- Autism Disorder
- Autism
- ADHD - Attention Deficit Disorder With Hyperactivity
- ADHD
- ASD
- Alcohol Abuse/Dependence
- Alcohol Addiction
- Alcohol and Other Drug Use Disorders
- Alcohol and Other Substance Use Prevention
- Gambling Addiction
- Gambling Disorder
- Sex Abuse
- Sex Behavior
- Sex Crimes
- Sex Disorder
- Sex Disorders
- Gender Dysphoria, Adult
- Eating Behavior Disorders
- Narcotic-Related Disorders
- Narcotic Addiction
- Narcissism
- Psychiatric Disorder
- Psychedelic Effects in Healthy Volunteers
- Psychedelic Experiences
- Psychedelic Drug Dependence
- Marijuana Use Disorder
- Marijuana Abuse and Dependence
- Smoking (Tobacco) Addiction
- Smoking Among Youth
- Smoking Abstinence
- Abstinence, Sex
- Opiate Substitution Treatment
- Opioid Abuse (Disorder)
- Opioid Abuse and Addiction
- Cocaine Abuse
- MDMA ('Ecstasy')
- Addiction Disorders
- Homeless and Low Incomes People, Refugees
- Homelessness
- Reliability and Validity
- Anger Problems
- Child Abuse, Sexual
Interventions
- AI City Hall Project (AIhealth4u - Public Health Central) Behavioral
- AI City Hall Project (QAIAx Microcity A - AI Public Health Central) Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 17 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2026
- Primary completion
- Sep 29, 2028
- Completion
- Dec 30, 2028
- Last update posted
- Jun 21, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Administrative Office | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07661823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07661823 live on ClinicalTrials.gov.